Market Overview

Benzinga's Top Upgrades, Downgrades For October 30, 2018

Share:

Top Upgrades

  • Wedbush upgraded Nordstrom, Inc. (NYSE: JWN) from Neutral to Outperform. Nordstrom shares rose 2 percent to $63.86 in pre-market trading.
  • Analysts at Benchmark upgraded Amedisys Inc (NASDAQ: AMED) from Hold to Buy. Amedisys shares closed at $100.89 on Monday.
  • Bank of America upgraded Old Dominion Freight Line (NASDAQ: ODFL) from Neutral to Buy. Old Dominion Freight shares closed at $120.61 on Monday.
  • Credit Suisse upgraded Hershey Co (NYSE: HSY) from Underperform to Neutral. Hershey shares closed at $106.00 on Monday.
  • JP Morgan upgraded NVIDIA Corporation (NASDAQ: NVDA) from Neutral to Overweight. NVIDIA shares rose 0.2 percent to $186.00 in pre-market trading.
  • First Analysis upgraded Chegg Inc (NYSE: CHGG) from Neutral to Outperform. Chegg shares rose 9.7 percent to $25.22 in pre-market trading.
  • Deutsche Bank upgraded Charles Schwab Corporation (NYSE: SCHW) from Hold to Buy. Charles Schwab shares rose 1.6 percent to $44.39 in pre-market trading.
  • JP Morgan upgraded JetBlue Airways Corporation (NASDAQ: JBLU) from Neutral to Overweight. JetBlue shares rose 2.1 percent to $16.50 in pre-market trading.
  • Barclays upgraded Hess Corp. (NYSE: HES) from Underweight to Equal-Weight. Hess shares closed at $56.16 on Monday.
  • KeyBanc upgraded Werner Enterprises, Inc. (NASDAQ: WERN) from Sector Weight to Overweight. Werner Enterprises shares fell 0.73 percent to close at $31.42 on Monday.

 

Top Downgrades

  • Raymond James downgraded E*TRADE Financial Corp (NASDAQ: ETFC) from Strong Buy to Outperform. E*TRADE shares closed at $47.69 on Monday.
  • JP Morgan downgraded Southwest Airlines Co (NYSE: LUV) from Neutral to Underweight. Southwest shares fell 1.7 percent to $47.11 in pre-market trading.
  • JP Morgan downgraded Spirit Airlines Incorporated (NYSE: SAVE) from Overweight to Neutral. Spirit Airlines shares closed at $52.09 on Monday.
  • Citigroup downgraded Vale SA (NYSE: VALE) from Buy to Neutral. Vale shares rose 0.4 percent to $14.32 in pre-market trading.
  • Bank of America downgraded Genuine Parts Company (NYSE: GPC) from Neutral to Underperform. Genuine Parts shares closed at $99.75 on Monday.
  • Citigroup downgraded Weatherford International plc (NYSE: WFT) from Neutral to Sell. Weatherford shares rose 1.3 percent to $1.56 in pre-market trading.
  • Wedbush downgraded Dillard's, Inc. (NYSE: DDS) from Outperform to Neutral. Dillard's shares closed at $74.28 on Monday.
  • Nomura downgraded Red Hat Inc (NYSE: RHT) from Buy to Neutral. Red Hat shares fell 1 percent to $167.90 in pre-market trading.
  • Argus downgraded Laboratory Corp. of America Holdings (NYSE: LH) from Buy to Hold. Laboratory Corp shares closed at $158.11 on Monday.

 

Top Initiations

  • Analysts at Citigroup initiated coverage on Elastic NV (NYSE: ESTC) with a Neutral rating. The price target for Elastic is set to $74. Elastic closed at $62.44 on Monday.
  • Jefferies initiated coverage on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) with a Buy rating. The price target for Kalvista Pharmaceuticals is set to $30. Kalvista Pharmaceuticals shares closed at $18.61 on Monday.
  • JP Morgan initiated coverage on Ventas, Inc. (NYSE: VTR) with a Neutral rating. The price target for Ventas is set to $60. Ventas shares closed at $57.26 on Monday.
  • Analysts at Barclays initiated coverage on Iridium Communications Inc (NASDAQ: IRDM) with an Overweight rating. The price target for Iridium Communications is set to $26. Iridium Communications shares closed at $17.86 on Monday.
  • Analysts at Nomura initiated coverage on salesforce.com, inc. (NYSE: CRM) with a Buy rating. The price target for salesforce.com is set to $181. salesforce.com shares closed at $130.99 on Monday.
  • BMO Capital initiated coverage on Livent Corp (NYSE: LTHM) with a Market Perform rating. The price target for Livent is set to $18. Livent shares closed at $15.55 on Monday.
  • H.C. Wainwright initiated coverage on ADMA Biologics Inc (NASDAQ: ADMA) with a Buy rating. The price target for ADMA Biologics is set to $17. ADMA Biologics shares closed at $5.03 on Monday.
 

Related Articles (AMED + ADMA)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
TWTROppenheimerMaintains55.0
FBTruist SecuritiesMaintains310.0
AMZNBenchmarkMaintains4,000.0
GOOGLDeutsche BankMaintains2,250.0
FBWells FargoMaintains330.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com